AzTrials
AzTrials

Sports InjuryPhase 1NCT04659447

Clinical Study of Platelet-rich Plasma Promoting Tendon-bone Healing in Anterior Cruciate Ligament Reconstruction

A Phase 1 study testing Platelet-Rich Plasma in people with Sports Injury, run by Beijing Tsinghua Chang Gung Hospital.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Anterior cruciate ligament (ACL) injury is a common knee injury, which seriously affects the living ability and sport level of the injured. ACL reconstruction is the main method to treat ACL injury. Read more about this study

Who is it for?
Ages 15 to 50 years
Conditions the study is for
Sports Injury
What is being tested?
Platelet-Rich Plasma
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
No sites listed yet
Study dates
1 Jul 2016to 9 Nov 2021
Phase
Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 50 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • History of knee injury
  • History of knee instability
  • Anterior drawer test (+), or / and Lachman test (+)
  • The tear of anterior cruciate ligament was confirmed by MRI

Who cannot join

  • The injury of other ligaments of knee joint, such as complex posterior cruciate ligament injury, lateral collateral ligament injury and medial collateral ligament injury above III degree
  • Patients with meniscus removed
  • Patients with moderate to severe articular cartilage injury
  • Patients with complex nerves and blood vessels injury
  • Patients with compound intra - and periarticular fractures of the knee
  • Patients with intra or periarticular fractures of the knee
  • Patients with contralateral knee instability
  • Patients with severe cardiovascular and cerebrovascular diseases

About this study

Anterior cruciate ligament (ACL) injury is a common knee injury, which seriously affects the living ability and sport level of the injured. ACL reconstruction is the main method to treat ACL injury. Due to the reconstructive ligament needs a tendon bone healing and ligament maturation, therefore, in the ACL anatomical study, reconstruction surgery and reconstruction materials under the condition of constant progress, how to improve the ACL reconstruction of tendon bone healing and shorten the time of the ligament mature, improve the clinical effect of ACL reconstruction, has become the focus in the ACL reconstruction.

Autologous platelet-rich plasma (PRP) is full of growth factors and bioactive factors, which has the function of promoting tissue healing, anti-inflammatory and analgesic effects. At the same time of anterior cruciate ligament reconstruction, using autologous PRP in the bone channel might promote tendon bone healing and ligament maturing after ACL reconstruction, promote the recovery of proprioception, prevent bone channel expanding, shorten the postoperative recovery time, speed up the patients recovery exercise ability, improve the clinical effect of ACL reconstruction.

In this study, patients with ACL injuries were randomly divided into two groups: one group underwent ACL anatomical reconstruction, and the other group underwent ACL anatomical reconstruction with PRP. Various clinical scores, KT-2000, Biodex and imaging tests were used to evaluate the differences in the clinical effects of the two surgical methods in terms of postoperative pain, joint swelling, knee function, joint stability, muscle strength recovery, bone channel expanding, ligament vasinization, and ligament maturation.

Conditions
Sports Injury
Being tested
Platelet-Rich Plasma
Keywords
Anterior Cruciate Ligament Tear, platelet-rich plasma
Medical subject headings
Athletic Injuries, Anterior Cruciate Ligament Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Platelet-Rich PlasmaDrug

    36 ml of peripheral blood is extracted from patients, and 4 ml of 3.8% sodium citrate is added for anticoagulation. After centrifugation for 2 times, 4 ml platelet-rich plasma will be prepared.Four semitendinosus tendons and gracilis tendons are prepared.

Study groups in NCT04659447
Study groupRoleWhat they receive
Platelet-Rich PlasmaExperimentalFour semitendinosus tendons and gracilis tendons are prepared. 4 ml platelet-rich plasma is completely absorbed by a gelatin sponge and fixed in the center of the four tendons. 4-0 absorbable line is used for fixation.Then we use conventional surgical techniques to reconstruct the ACL.
Receives: Drug: Platelet-Rich Plasma
control groupNo interventionWe performed conventional surgical techniques to reconstruction without using platelet-rich plasma.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. tendon bone healing and ligament maturing

    The diameter of bone canal was evaluated by CT, it is measured in millimeters (mm).

    The tendon bone healing and ligament maturing was evaluated by MRI. According to the same level of anterior cruciate ligament, femoral canal, posterior cruciate ligament, background noise, with the diameter of 3.3 mm as the center, the lowest signal value point was measured, and the final point was compared to obtain the Signal-Noise Ratio.

    Measured: CT and MRI were performed on the fourth day after operation

  2. tendon bone healing and ligament maturing

    The diameter of bone canal was evaluated by CT, it is measured in millimeters (mm).

    The tendon bone healing and ligament maturing was evaluated by MRI. According to the same level of anterior cruciate ligament, femoral canal, posterior cruciate ligament, background noise, with the diameter of 3.3 mm as the center, the lowest signal value point was measured, and the final point was compared to obtain the Signal-Noise Ratio.

    Measured: CT and MRI were performed on one year after operation

  3. proprioception and Knee joint function

    KT-2000, it was used to assess the stability of the tibia and the results were expressed in millimeters.

    Biodex, it is used to assess the strength and function of joints. The contralateral knee joint was taken as the reference. The percentage of strength between the affected knee joint and the contralateral knee joint was obtained

    Measured: 3 months after the operation

  4. proprioception and Knee joint function

    KT-2000, it was used to assess the stability of the tibia and the results were expressed in millimeters.

    Biodex, it is used to assess the strength and function of joints. The contralateral knee joint was taken as the reference. The percentage of strength between the affected knee joint and the contralateral knee joint was obtained

    Measured: 6 months after the operation

  5. proprioception and Knee joint function

    KT-2000, it was used to assess the stability of the tibia and the results were expressed in millimeters.

    Biodex, it is used to assess the strength and function of joints. The contralateral knee joint was taken as the reference. The percentage of strength between the affected knee joint and the contralateral knee joint was obtained

    Measured: 1 year after the operation

  6. Knee pain

    Visual Analog Score for pain, it is used to assess the patient's pain, the full score is 10.

    Measured: 3 months after the operation

  7. Knee pain

    Visual Analog Score for pain, it is used to assess the patient's pain, the full score is 10.

    Measured: 6 months after the operation

  8. Knee pain

    Visual Analog Score for pain, it is used to assess the patient's pain, the full score is 10.

    Measured: 1 year after the operation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Dec 2020
  2. Study start1 Jul 2016
  3. Primary completion9 Nov 2021 (estimated)
  4. Study completion9 Nov 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04659447
Sponsor's protocol ID
12017B3003
Status last verified
Dec 2020
First submitted
23 Nov 2020
Last updated
9 Dec 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Gong H, Huang B, Zheng Z, Fu L, Chen L. Clinical Use of Platelet-Rich Plasma to Promote Tendon-Bone Healing and Graft Maturation in Anterior Cruciate Ligament Reconstruction-A Randomized Controlled Study. Indian J Orthop. 2022 Jan 27;56(5):805-811. doi: 10.1007/s43465-021-00533-z. eCollection 2022 May.

    PubMed 35103026

Questions about this trial

What is this clinical trial studying?

A Phase 1 study testing Platelet-Rich Plasma in people with Sports Injury, run by Beijing Tsinghua Chang Gung Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Dec 2020. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

tendon bone healing and ligament maturing (time frame: CT and MRI were performed on the fourth day after operation). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04659447, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Dec 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in